Publications by authors named "Jessica Hervol"
Article Synopsis
- A study was conducted using Medicare data to evaluate the effectiveness of a third COVID-19 vaccine dose among beneficiaries aged 65 and older during the Omicron variant surge.
- The results showed that 73.3% of the eligible individuals had received a third dose by March 2022, and it significantly reduced the risk of hospitalization and death, especially within the first 60 days.
- However, the added protection from the third dose declined after four months, highlighting the importance of ongoing vaccination efforts.
In the United States, most new cases of human immunodeficiency virus (HIV) belong to the at-risk group of gay and bisexual men. Developing therapies to reverse viral latency and prevent spread is paramount for the HIV cure agenda. In gay and bisexual men, a major, yet poorly characterized, route of HIV entry is via transport across the colonic epithelial barrier.
View Article and Find Full Text PDF